Army, U.S
[39] These findings support a potential clinical role for oral orforglipron as a step-down or maintenance strategy after injectable GLP-1 or dual GIP/GLP-1 receptor agonist therapy, although long-term implementation depends on labeling, access, tolerability, and comparative durability
Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD
Four to eight weeks is a minimum for most shoulder conditions, with twelve weeks or more being appropriate for significant tears or chronic tendinopathy
doi: 10.1056/NEJMoa1509225 20 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFENauckMAet al
Note for Medicare patients that there is an NCCI edit in place that bundles the fluoroscopy into the CT and MRI codes